NASDAQ:ZYBT Zhengye Biotechnology Q4 2025 Earnings Report $1.37 +0.09 (+7.03%) Closing price 09/23/2026 04:00 PM EasternExtended Trading$1.34 -0.03 (-2.19%) As of 08:49 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Zhengye Biotechnology EPS ResultsActual EPS-$0.08Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AZhengye Biotechnology Revenue ResultsActual Revenue$3.97 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AZhengye Biotechnology Announcement DetailsQuarterQ4 2025Date4/28/2026TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Zhengye Biotechnology Earnings HeadlinesZhengye Biotechnology Holding Ltd (ZYBT)August 28, 2026 | ru.investing.comZhengye Biotechnology Regains Nasdaq Minimum Bid Price ComplianceAugust 6, 2026 | tipranks.comHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its valuation has doubled since the announcement, with some estimates putting the company's worth near 3 trillion dollars by IPO day. Google, Amazon, Nvidia and Microsoft have all taken stakes, while Goldman Sachs, Morgan Stanley and JPMorgan are competing for private shares. Anthropic's annualized revenue reportedly grew 80 times in the first quarter alone. See how investors are positioning ahead of this closely watched IPO.September 24 at 1:00 AM | Weiss Ratings (Ad)Why Zhengye Biotechnology Holding (ZYBT) Stock Is Up TodayAugust 5, 2026 | quiverquant.comQZhengye Biotechnology Stock Short Interest Report | NASDAQ:ZYBT | BenzingaJuly 23, 2026 | benzinga.comZhengye Biotechnology Addresses Unusual Nasdaq Trading ActivityJuly 21, 2026 | tipranks.comSee More Zhengye Biotechnology Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Zhengye Biotechnology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Zhengye Biotechnology and other key companies, straight to your email. Email Address About Zhengye BiotechnologyZhengye Biotechnology (NASDAQ:ZYBT) Group Co., Ltd. (NASDAQ: ZYBT) is a China-based biotechnology company focused on the research, development, manufacture and sale of biological products for animal use. The company serves the veterinary and animal-health markets, with products intended to help prevent and manage infectious diseases in livestock and other animals. Its product portfolio is centered on veterinary vaccines and related biological products. Zhengye Biotechnology also offers other animal-health products and services associated with disease prevention and herd health management. Its customers include participants in China’s animal husbandry and veterinary sectors. The company operates primarily in China through its operating subsidiaries and has been associated with the development and production of animal biological products. Publicly available information about its historical operations and leadership is limited, so further details regarding its management team and international activities are not included here.View Zhengye Biotechnology ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Energy Transfer Taps the AI Power BoomFull Throttle: Kratos and GE Fire Up a Next-Gen Defense EngineSandisk Joins the S&P 100—Is the Index Flow, or the AI Story, Driving the Stock?Thor Industries Is Boring—And That May Be Its Biggest AdvantageAutoZone Shifts Gears, On Track to Reverse Course and Price RecoveryMeta’s Muse Highlights Arm’s Growing Role in AI InfrastructureOld Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
